0001567619-19-016171.txt : 20190809 0001567619-19-016171.hdr.sgml : 20190809 20190809170435 ACCESSION NUMBER: 0001567619-19-016171 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190808 FILED AS OF DATE: 20190809 DATE AS OF CHANGE: 20190809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAZELSKY JAY CENTRAL INDEX KEY: 0001556270 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 191013680 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2019-08-08 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001556270 MAZELSKY JAY ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Interim President & CEO Common Stock 2019-08-08 4 M 0 2204 45.84 A 25474 D Common Stock 2019-08-08 4 M 0 2848 47.53 A 28322 D Common Stock 2019-08-08 4 M 0 6306 47.53 A 34628 D Non-Qualified Stock Option (right-to-buy) 45.84 2019-08-08 4 M 0 2204 D 2020-02-13 Common Stock 2204 13824 D Non-Qualified Stock Option (right-to-buy) 47.53 2019-08-08 4 M 0 2848 D 2019-08-31 Common Stock 2848 0 D Incentive Stock Option (right-to-buy) 47.53 2019-08-08 4 M 0 6306 D 2019-08-31 Common Stock 6306 0 D Grant of option to buy 13,014 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2014 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Grant of option to buy 1,424 shares of Issuer common stock that became exercisable in five annual installments beginning September 1, 2013 without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Grant of option to buy 5,255 shares of Issuer common stock that became exercisable in five annual installments beginning September 1, 2013 without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Jay Mazelsky 2019-08-09